Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-27 · accession 0001601830-25-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-28 | 2025-03-27 | RXRX | Gibson Christopher | CEO, Dir | S - Sale | $6.04 | -138.6K | 1.12M | -11% | -$837.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-27 | S | D | 138,574 | $6.04 | 1,117,450 | D | — | — |